|
IVR101/2 – Topical Antifungal Onychomychosis
Ivrea is developing topically applied gels for the treatment of onychomycosis. In later stages of clinical development, IVR101/102 are intended to offer the safety of topical application while simultaneously providing the efficacy associated with oral medications. Compared to lacquers, our gels are also less likely to cause irritation to the surrounding skin.
IVR103 – Topical Retinoid
IVR103 is specifically designed to reduce the level of irritation associated with all trans retinoic acid (also called tretinoin) while maintaining efficacy in treating acne lesions.
|
